Literature DB >> 20729792

Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17α in preeclampsia.

Ji Hyae Lim1, Shin Young Kim, Do Jin Kim, So Yeon Park, Ho Won Han, Jung Yeol Han, Si Won Lee, Jae Hyug Yang, Hyun Mee Ryu.   

Abstract

OBJECTIVE: Catechol-O-methyltransferase (COMT) and cytochrome P450c17α (CYP17A1) are key enzymes involved in the metabolism of steroid hormones; genetic polymorphisms in these genes affect enzyme activity. Recently, functional polymorphisms in the COMT and CYP17A1 genes have been suggested as a susceptible marker for intrauterine fetal growth restriction, a typical complication of preeclampsia. Moreover, a close association between COMT and preeclampsia was reported. We therefore investigated the relationships between COMT and CYP17A1 polymorphisms and the risk of preeclampsia.
METHODS: A total of 164 preeclamptic women and 182 normotensive women were enrolled. COMT (Val158Met) and CYP17A1 (-34T/C) polymorphisms were genotyped by quantitative fluorescent-polymerase chain reaction. Multiple logistic regression analysis was used to estimate the risks of preeclampsia according to genotypes.
RESULTS: The adjusted odds ratios (adjOR) for the risks of preeclampsia, severe preeclampsia and preeclampsia for small-for-gestational-age (SGA) infants were 1.97 [95% confidence interval (CI): 1.02-3.83], 3.29 (95% CI: 1.60-6.77), and 4.05 (95% CI: 1.78-9.22), respectively, in women homozygous for the variant COMT allele. No significant differences were observed between the two groups with respect to CYP17A1 polymorphisms, indicating that variants of this gene have no effects on preeclampsia. The highest risks of preeclampsia were found among women with homozygous variant genotypes of both genes [adjOR (95% CI): 4.58 (1.92-22.81)]. Moreover, the adjOR for preeclamptic complications in those women was 5.09 (95% CI: 1.93-27.88) for severe preeclampsia and 15.65 (95% CI: 3.19-76.82) for SGA preeclampsia.
CONCLUSION: These findings suggest that homozygosity for the variant allele of the maternal COMT gene may increase susceptibility to preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729792     DOI: 10.1097/FPC.0b013e32833df033

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  9 in total

1.  Allelic and genotype frequencies of catechol-O-methyltransferase (Val158Met) and CYP2D6*10 (Pro34Ser) single nucleotide polymorphisms in the Philippines.

Authors:  Michael O Baclig; Rey Z Predicala; Cynthia A Mapua; Jingky P Lozano-Kühne; Maria Luisa G Daroy; Filipinas F Natividad; Francis O Javier
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

2.  A Comparison of 2-Methoxyestradiol Value in Women with Severe Preeclampsia Versus Normotensive Pregnancy.

Authors:  John Wantania; Ahsanuddin Attamimi; Rukmono Siswishanto
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 3.  Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia.

Authors:  Alejandra Perez-Sepulveda; Pedro P España-Perrot; Errol R Norwitz; Sebastián E Illanes
Journal:  Reprod Sci       Date:  2013-03-01       Impact factor: 3.060

4.  2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia.

Authors:  Miriam Pertegal; Francisco J Fenoy; Barbara Bonacasa; Jaime Mendiola; Juan L Delgado; Moises Hernández; Miguel G Salom; Vicente Bosch; Isabel Hernández
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

5.  A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2).

Authors:  L T Roten; M H Fenstad; S Forsmo; M P Johnson; E K Moses; R Austgulen; F Skorpen
Journal:  Mol Hum Reprod       Date:  2011-02-25       Impact factor: 4.025

6.  Evaluation of Glutathione Peroxidase 4 role in Preeclampsia.

Authors:  Xinguo Peng; Yan Lin; Jinling Li; Mengchun Liu; Jingli Wang; Xueying Li; Jingjing Liu; Xuewen Jia; Zhongcui Jing; Zuzhou Huang; Kaiqiu Chu; Shiguo Liu
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

7.  Protective Role of Maternal P.VAL158MET Catechol-O-Methyltransferase Polymorphism against Early-Onset Preeclampsia and its Complications.

Authors:  Tijana Krnjeta; Ljiljana Mirković; Svetlana Ignjatović; Dragana Tomašević; Jelena Lukić; Drina Topalov; Ivan Soldatović; Nada Majkić-Singh
Journal:  J Med Biochem       Date:  2016-07-06       Impact factor: 3.402

8.  Catechol-O-methyltransferase and Pregnancy Outcome: an Appraisal in Rat.

Authors:  Khursheed Iqbal; Pramod Dhakal; Stephen H Pierce; Michael J Soares
Journal:  Reprod Sci       Date:  2020-10-13       Impact factor: 3.060

9.  Exploration of CYP21A2 and CYP17A1 polymorphisms and preeclampsia risk among Chinese Han population: a large-scale case-control study based on 5021 subjects.

Authors:  Bo Hou; Xuewen Jia; Ziwen Deng; Xin Liu; Huitang Liu; Haichu Yu; Shiguo Liu
Journal:  Hum Genomics       Date:  2020-09-25       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.